ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
Transkaryotic Therapies  (MM)

Transkaryotic Therapies (MM) (TKTX)

0.00
0.00
(0.00%)
終了 9月22日 5:00AM
0.00
0.00
(0.00%)
取引時間後: -

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

主要統計と詳細

通貨
-
買値
-
売値
-
出来高
-
0.00 日の範囲 0.00
0.00 52 週間の範囲 0.00
前日終値
-
始値
-
時刻
最終取引時間
平均取引量 (3 か月)
-
財務取引量
-
VWAP
-

TKTX 最新ニュース

CRISPR Therapeutics Proposes Changes to the Board of Directors

ZUG, Switzerland and CAMBRIDGE, Mass., Feb. 26, 2020 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines...

TKT Stockholders Approve Acquisition by Shire

TKT Stockholders Approve Acquisition by Shire CAMBRIDGE, Mass., July 27 /PRNewswire-FirstCall/ -- Transkaryotic Therapies, Inc. (NASDAQ:TKTX) today announced that TKT stockholders approved...

TKT Confirms That Board of Directors Unanimously Recommends That Stockholders Approve Shire Transaction

TKT Confirms That Board of Directors Unanimously Recommends That Stockholders Approve Shire Transaction CAMBRIDGE, Mass., July 14 /PRNewswire-FirstCall/ -- Transkaryotic Therapies, Inc...

TKT Issues Open Letter to Stockholders

TKT Issues Open Letter to Stockholders Board of Directors Urges TKT Stockholders to Vote 'FOR' Shire Transaction CAMBRIDGE, Mass., July 12 /PRNewswire-FirstCall/ -- Transkaryotic Therapies, Inc...

TKT to Hold Special Meeting of Stockholders on July 27, 2005

TKT to Hold Special Meeting of Stockholders on July 27, 2005 CAMBRIDGE, Mass., June 27 /PRNewswire-FirstCall/ -- Transkaryotic Therapies, Inc. (NASDAQ:TKTX) today announced its plans to hold a...

TKT Reports Positive Top-Line Results of Hunter Syndrome Pivotal Trial

TKT Reports Positive Top-Line Results of Hunter Syndrome Pivotal Trial Primary Endpoint Achieves Statistical Significance CAMBRIDGE, Mass., June 20 /PRNewswire-FirstCall/ -- Transkaryotic...

TKT Announces Expiration of Both Hart-Scott-Rodino Waiting Period and SEC Review Period of Preliminary Proxy Statement

TKT Announces Expiration of Both Hart-Scott-Rodino Waiting Period and SEC Review Period of Preliminary Proxy Statement CAMBRIDGE, Mass., June 13 /PRNewswire-FirstCall/ -- Transkaryotic...

TKT Announces First Quarter 2005 Results

TKT Announces First Quarter 2005 Results CAMBRIDGE, Mass., May 5 /PRNewswire-FirstCall/ -- Transkaryotic Therapies, Inc. (NASDAQ:TKTX) today announced its consolidated financial results for...

TKT Assessing Impact of Fire at Manufacturing Facility

TKT Assessing Impact of Fire at Manufacturing Facility CAMBRIDGE, Mass., April 27 /PRNewswire-FirstCall/ -- Transkaryotic Therapies, Inc. (NASDAQ:TKTX) announced that a fire occurred yesterday...

TKT to Report First Quarter 2005 Financial Results on May 5, 2005

TKT to Report First Quarter 2005 Financial Results on May 5, 2005 CAMBRIDGE, Mass., April 27 /PRNewswire-FirstCall/ -- Transkaryotic Therapies, Inc. (NASDAQ:TKTX) will announce its first quarter...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
BNZIBanzai International Inc
US$ 5.645
(96.01%)
61.39M
ZJYLJin Medical International Ltd
US$ 3.975
(50.00%)
1.24M
ANEBAnebulo Pharmaceuticals Inc
US$ 2.9001
(39.43%)
78.85k
XPONExpion360 Inc
US$ 0.081
(39.18%)
1.46B
AENTAlliance Entertainment Holding Corporation
US$ 2.74
(34.31%)
4.23M
GSIWGarden Stage Ltd
US$ 1.34
(-82.89%)
26.44M
CRBPCorbus Pharmaceuticals Holdings Inc
US$ 19.51
(-62.26%)
12.29M
LGCBLinkage Global Inc
US$ 0.4183
(-57.70%)
2.16M
BFIBurgerFi International Inc
US$ 0.0855
(-42.27%)
15.05M
SKYESkye Bioscience Inc
US$ 3.17
(-42.26%)
5.14M
XPONExpion360 Inc
US$ 0.081
(39.18%)
1.46B
NVDANVIDIA Corporation
US$ 116.00
(-1.59%)
378.16M
AAPLApple Inc
US$ 228.20
(-0.29%)
320.24M
INTCIntel Corporation
US$ 21.84
(3.31%)
261.68M
VERBVerb Technology Company Inc
US$ 0.0742
(33.45%)
178.65M

最近閲覧した銘柄

Delayed Upgrade Clock